Two patients walk into a clinic...a genomics perspective on the future of schizophrenia

Two patients walk into a clinic...a genomics perspective on the future of schizophrenia

Blog Article

Abstract Progress is being made in schizophrenia genomics, suggesting that this complex brain disorder involves rare, moderate to high-risk mutations and the cumulative impact of small genetic effects, coupled with environmental majicontrast red factors.The genetic heterogeneity underlying schizophrenia and the overlap with other neurodevelopmental disorders suggest that it will not continue to be viewed as folk rivet sweat a single disease.This has radical implications for clinical practice, as diagnosis and treatment will be guided by molecular etiology rather than clinical diagnostic criteria.